Lipoprotein phospholipase A2 (Lp-PLA2) immunofluorescence probe detection kit

An immunofluorescence and probe detection technology, which is applied in the field of medical products, can solve problems such as failure to warn, lose the meaning of prevention, and abnormal indicators, and achieve the effects of saving time, good sensitivity, and wide detection range

Inactive Publication Date: 2016-01-27
上海凯璟生物科技有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it is still impossible to warn of the risk of myocardial infarction at any time due to the aggravation of atherosclerotic plaque inflammation in blood vessels
[0006] 3) The detection of electrocardiogram and various myocardial enzymes is an abnormal index that occurs after myocardial infarction, so it loses the meaning of prevention

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Lipoprotein phospholipase A2 (Lp-PLA2) immunofluorescence probe detection kit
  • Lipoprotein phospholipase A2 (Lp-PLA2) immunofluorescence probe detection kit
  • Lipoprotein phospholipase A2 (Lp-PLA2) immunofluorescence probe detection kit

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0036] 1. Preparation of Lp-PLA2 detection probe:

[0037] Two mouse anti-human Lp-PLA2 monoclonal antibody I and mouse anti-human Lp-PLA2 monoclonal antibody II with good specificity and high sensitivity were selected.

[0038] 1.1 Labeled antibody: Use UCP to label mouse anti-human Lp-PLA2 monoclonal antibody I for standby;

[0039] 1.2 Preparation of blood filter membrane: Dilute the antibody labeled fluorescent microspheres with PBS of Ph7.410mmol / L to a certain concentration solution, soak the blood filter membrane in the solution for 2 hours, take it out and put it in a constant temperature drying oven to dry at 37°C 16h standby;

[0040] 1.3 Preparation of the detection chip: Spot the mouse anti-human Lp-PLA2 monoclonal antibody II and the rabbit anti-mouse IgG antibody on the NC membrane with a chip spotter, freeze-dry overnight, and set aside.

[0041] 1.4 Assembly: Fix the NC membrane to the device in the reaction area of ​​the detection chip, put the hemofiltratio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention discloses a self-designed immunofluorescence probe detection system for quantitative detection of risk predictive factor Lp-PLA2 of arteriosclerosis cerebral infarction for predicting whether a patient may be subjected to atheroma heart disease. The immunofluorescence probe detection system comprises a sample collection system, a reaction detection system, a laser emission system, a fluorescence collection system and a fluorescence conversion system. The probe is connected with a negative-pressure device to successively enter a collected blood sample into a blood filter device for filtering the blood samples, then into a sample boding zone to combine with fluorescent microsphere labeled antibodies, and finally into a sample detection zone to combine with coated antibodies, and namely, the blood sample exists in Ab-Ag (sample)-Ab (fluorescent microsphere labeled) sandwich complex form. By laser irradiating, the labeled antibodies are excited to produce fluorescence, a fluorescence signal is transferred to a fluorescence photosensitive area by a fluorescence conduction device, and the fluorescence signal is converted into a digital signal, and then converted into a sample concentration signal. The characteristics of the self-designed immunofluorescence probe detection system are that: the probe is used for rapid detection of the heart disease predictive factor Lp-PLA2, the collection of blood samples to detection of the results can be completed within 5 minutes, detection is rapid and accurate, operation is simple, and the risk of sudden heart attack of the patient can be earlier and faster forecasted. The immunofluorescence probe detection system is a separable device, and can pass through the design of different projects.

Description

technical field [0001] The present invention is based on a self-designed immunofluorescence probe detection system to quantitatively detect the risk predictor Lp-PLA2 of arteriosclerosis and cerebral infarction, which belongs to the field of medical products. Background technique [0002] Coronary artery disease, also known as coronary heart disease (CHD), is a heart disease caused by atherosclerotic lesions in the coronary arteries that cause stenosis or blockage of the vessel lumen, resulting in myocardial ischemia, hypoxia or necrosis. The occurrence and development of coronary atherosclerosis is a chronic inflammatory process. Chronic inflammation is considered to increase the risk factors of coronary artery disease and make atherosclerotic plaques prone to rupture. In recent years, studies have found that lipoprotein-associated phospholipase A2 is a new predictor of coronary heart disease, and pointed out that it is closely related to atherosclerotic lesions. Lp-PLA2, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68G01N33/577G01N33/533
CPCG01N33/68G01N33/533G01N33/577
Inventor 罗朝领刘红水侍崇晓
Owner 上海凯璟生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products